Correlation Between Merck and BOSTON

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and BOSTON at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and BOSTON into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and BOSTON PPTYS LTD, you can compare the effects of market volatilities on Merck and BOSTON and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of BOSTON. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and BOSTON.

Diversification Opportunities for Merck and BOSTON

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between Merck and BOSTON is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and BOSTON PPTYS LTD in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BOSTON PPTYS LTD and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with BOSTON. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BOSTON PPTYS LTD has no effect on the direction of Merck i.e., Merck and BOSTON go up and down completely randomly.

Pair Corralation between Merck and BOSTON

Considering the 90-day investment horizon Merck Company is expected to generate 1.58 times more return on investment than BOSTON. However, Merck is 1.58 times more volatile than BOSTON PPTYS LTD. It trades about -0.03 of its potential returns per unit of risk. BOSTON PPTYS LTD is currently generating about -0.22 per unit of risk. If you would invest  10,423  in Merck Company on August 29, 2024 and sell it today you would lose (112.50) from holding Merck Company or give up 1.08% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy86.96%
ValuesDaily Returns

Merck Company  vs.  BOSTON PPTYS LTD

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
BOSTON PPTYS LTD 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BOSTON PPTYS LTD has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, BOSTON is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Merck and BOSTON Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and BOSTON

The main advantage of trading using opposite Merck and BOSTON positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, BOSTON can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BOSTON will offset losses from the drop in BOSTON's long position.
The idea behind Merck Company and BOSTON PPTYS LTD pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios